Literature DB >> 29965952

Measurement Characteristics of the Knowledge Assessment of Renal Transplantation.

John D Peipert1, Ron D Hays2, Satoru Kawakita3, Jennifer L Beaumont3, Amy D Waterman3,4.   

Abstract

BACKGROUND: Kidney transplant is the best treatment for most end-stage renal disease (ESRD) patients, but proportionally few ESRD patients receive kidney transplant. To make an informed choice about whether to pursue kidney transplant, patients must be knowledgeable of its risks and benefits. To reliably and validly measure ESRD patients' kidney transplant knowledge, rigorously tested measures are required. This article describes the development and psychometric testing of the Knowledge Assessment of Renal Transplantation (KART).
METHODS: We administered 17 transplant knowledge items to a sample of 1294 ESRD patients. Item characteristics and scale scores were estimated using an Item Response Theory graded response model. Construct validity was tested by examining differences in scale scores between patients who had spent less than 1 and 1 hour or longer receiving various types of transplant education.
RESULTS: Item Response Theory modeling suggested that 15 items should be retained for the KART. This scale had a marginal reliability of 0.75 and evidenced acceptable reliability (>0.70) across most of its range. Construct validity was supported by the KART's ability to distinguish patients who had spent less than 1 and 1 hour or longer receiving different types of kidney transplant education, including talking to doctors/medical staff (effect size [ES], 0.61; P < 0.001), reading brochures (ES, 0.45; P < 0.001), browsing the internet (ES, 0.56; P < 0.001), and watching videos (ES, 0.56; P < 0.001).
CONCLUSIONS: The final 15-item KART can be used to determine the kidney transplant knowledge levels of ESRD patients and plan appropriate interventions to ensure informed transplant decision making occurs.

Entities:  

Mesh:

Year:  2019        PMID: 29965952      PMCID: PMC6311148          DOI: 10.1097/TP.0000000000002349

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

Review 1.  Interventions for increasing solid organ donor registration.

Authors:  Alvin H Li; Marcus Lo; Jacob E Crawshaw; Alexie J Dunnett; Kyla L Naylor; Amit X Garg; Justin Presseau
Journal:  Cochrane Database Syst Rev       Date:  2021-04-04

2.  Measuring Patient Knowledge of Kidney Transplantation: An Initial Step to Close the Knowledge Gap.

Authors:  Laura J McPherson; Reem E Hamoda; Rachel E Patzer
Journal:  Transplantation       Date:  2019-03       Impact factor: 4.939

3.  The Knowledge Assessment of Renal Transplantation (KART) 2.0: Development and Validation of CKD and Transplant Knowledge Scales.

Authors:  Amy D Waterman; Devika Nair; Intan Purnajo; Kerri L Cavanaugh; Brian S Mittman; John Devin Peipert
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-24       Impact factor: 8.237

4.  Measuring Disease and Transplant Knowledge among Patients with Advanced CKD: Tools to Increase Access and Advance Equity.

Authors:  Megan A Urbanski; Rachel E Patzer
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-24       Impact factor: 8.237

5.  Is There Decreasing Public Interest in Renal Transplantation? A Google TrendsTM Analysis.

Authors:  Andreas Kronbichler; Maria Effenberger; Jae Il Shin; Christian Koppelstätter; Sara Denicolò; Michael Rudnicki; Hannes Neuwirt; Maria José Soler; Kate Stevens; Annette Bruchfeld; Herbert Tilg; Gert Mayer; Paul Perco
Journal:  J Clin Med       Date:  2020-04-07       Impact factor: 4.241

6.  Thematic analysis of the medical records of patients evaluated for kidney transplant who did not receive a kidney.

Authors:  Catherine R Butler; Janelle S Taylor; Peter P Reese; Ann M O'Hare
Journal:  BMC Nephrol       Date:  2020-07-25       Impact factor: 2.388

7.  Benefit of a pharmacist-led intervention for medication management of renal transplant patients: a controlled before-and-after study.

Authors:  Jeremy Chambord; Lionel Couzi; Pierre Merville; Karine Moreau; Fabien Xuereb; Sarah Djabarouti
Journal:  Ther Adv Chronic Dis       Date:  2021-04-05       Impact factor: 5.091

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.